Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.176SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.547SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.247SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.205SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.110SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.434SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.181SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.6.6SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.37SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BN.1.2.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
CQ.2SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
CH.1.1.24SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
BA.5.2.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.19SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.38.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.19.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BQ.1.1.43SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BA.5.2.12SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
BF.7.23SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.1.500SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.511SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.428.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.506SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.482SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.335SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.36.36SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.499.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.38SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.116SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.4.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.528SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.175SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.6.3SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.483SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.181SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.113SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.594SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.328SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.13SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.145SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.214SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.284SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.351.3 (Beta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
B.1.1.318SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
R.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
AY.29 (Delta)SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
ML.1SYoung-STATACATGTCTCTGGGACCA20452176321782F-13305.5Singapore
B.5SYoung-STATACATGTCTCTGGGACCA20452176321782F-19121.1Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used